Related Experiment Videos

Depression in coronary artery disease: novel pathophysiologic mechanisms and therapeutic implications

John T Parissis1, Katerina Fountoulaki, Gerasimos Filippatos

  • 1Second Department of Cardiology, Attikon University Hospital, Aftokratoros Irakliou 17, 15122 Maroussi, Athens, Greece. jparissis@yahoo.com

International Journal of Cardiology
|July 11, 2006
PubMed

Insights

Depression is common in coronary artery disease patients and increases cardiac risks. Treating depression, possibly with selective serotonin reuptake inhibitors, may improve outcomes and survival after heart attack.

Area of Science:

  • Cardiology
  • Psychiatry
  • Clinical Medicine

Background:

  • Depression frequently co-occurs with coronary artery disease (CAD).
  • Depression is a significant risk factor for adverse cardiac events and mortality in CAD patients.
  • The precise mechanisms linking depression and ischemic heart disease are not fully understood.

Purpose of the Study:

  • To review the prognostic significance of depression in patients with coronary artery disease.
  • To explore the pathophysiologic pathways involved in the depression-ischemia link.
  • To evaluate the impact of antidepressant therapy on cardiovascular outcomes.

Main Methods:

  • Literature review of current knowledge on depression and coronary artery disease.
  • Analysis of studies on pathophysiologic mechanisms.
  • Examination of evidence regarding antidepressant treatment effects on cardiac outcomes.

Main Results:

  • Depression negatively impacts prognosis in coronary artery disease patients.
  • Emerging evidence suggests selective serotonin reuptake inhibitors (SSRIs) may enhance survival post-myocardial infarction in depressed patients.
  • Understanding the interplay is crucial for comprehensive patient management.

Conclusions:

  • Depression is a critical comorbidity in coronary artery disease requiring clinical attention.
  • Antidepressant therapy, particularly SSRIs, shows potential benefits for cardiovascular outcomes.
  • Effective diagnosis and treatment of depression are essential for managing coronary artery disease patients.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...